3,4-dihydroxyphenylacetic acid has been researched along with selegiline in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (26.23) | 18.7374 |
1990's | 33 (54.10) | 18.2507 |
2000's | 12 (19.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaakkola, S; Wurtman, RJ | 1 |
Kuczenski, R; Okuda, C; Segal, DS | 1 |
Greenshaw, AJ; Juorio, AV; Paterson, IA; Zhu, MY | 1 |
Chan, WW; Rausch, WD; Riederer, P; Schallauer, E; Weiser, M | 1 |
Kumagae, Y; Matsui, Y | 1 |
Dluzen, DE; McDermott, JL | 1 |
Cedarbaum, JM; Clark, M; Harts, A; Kutt, H; Silvestri, M | 1 |
Garrett, MC; Soares-da-Silva, P | 1 |
Bradbury, AJ; Costall, B; Jenner, PG; Kelly, ME; Marsden, CD; Naylor, RJ | 1 |
Arai, Y; Kinemuchi, H; Kisara, K; Matsumura, T; Sakuma, I; Satoh, N; Tadano, T | 1 |
Kaarttinen, A; Kallio, J; Koulu, M; Pyykkö, K; Scheinin, M; Vuorinen, J; Zimmer, RH | 1 |
Greenshaw, AJ; Juorio, AV; Nguyen, TV | 1 |
Hashim, A; Lajtha, A; Sershen, H; Wiener, HL | 2 |
Goldstein, DS; Hovevey-Sion, D; Kopin, IJ; Stull, RW | 1 |
Bizière, K; Guillaumin, JM; Kan, JP; Renoux, G; Renoux, M; Steinberg, R | 1 |
Fuller, RW; Hemrick-Luecke, SK | 1 |
Bretton, C; Hof, P; Ofori, S; Schorderet, M | 1 |
Duvoisin, RC; Heikkila, RE; Nicklas, WJ | 1 |
Duvoisin, RC; Heikkila, RE; Hess, A | 1 |
Bocchetta, A; Corsini, GU; Del Zompo, M; Piccardi, MP; Pintus, S | 1 |
Baraczka, K; Fekete, MI; Kanyicska, B | 1 |
Hársing, LG; Vizi, ES | 1 |
Calne, DB; Chuang, LW; Eisler, T; Karoum, F; Klein, DF; Liebowitz, MR; Quitkin, FM; Wyatt, RJ | 1 |
Holdup, D; Liptrot, J; Phillipson, O | 1 |
Gupta, M; Wiener, HL | 1 |
Bankiewicz, KS; Finberg, JP; Goldstein, DS; Kopin, IJ; Wang, J | 1 |
Sivam, SP | 1 |
Corsini, GU; Fascetti, F; Fornai, F; Maggio, R; Vaglini, F | 1 |
Juorio, AV; Paterson, IA; Zhu, MY | 1 |
Bennett, JP; Parker, WD; Smith, TS | 1 |
Abercrombie, ED; Wachtel, SR | 1 |
Boulton, AA; Durden, DA; Dyck, LE | 1 |
Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ | 1 |
Boulton, AA; Davis, BA; Durden, DA; Ivy, G; Juorio, AV; Mendonca, A; Milgram, W; Paterson, IA; Wu, P; Yu, PH | 1 |
Burger, R; Dirr, A; Götz, ME; Rausch, WD; Riederer, P | 1 |
Finberg, JP; Lamensdorf, I; Youdim, MB | 1 |
Dingemanse, J; Kettler, R; Kneer, J; Korn, A; Koulu, M; Wallnöfer, A; Zürcher, G | 1 |
Chalmers-Redman, RM; Ju, WY; Tatton, NA; Tatton, WG; Wadia, JS | 1 |
Cano, J; Machado, A; Rodríguez-Gómez, JA; Romero-Ramos, M; Venero, JL | 1 |
Brannan, T; Martínez-Tica, J; Prikhojan, A; Yahr, MD | 1 |
Dhingra, NK; Lakshmana, MK; Meti, BL; Raju, TR; Rao, BS; Ravikumar, R; Sudha, S | 1 |
Iwata, S; Kaseda, S; Nomoto, M | 1 |
Finberg, JP; Lamensdorf, I; Porat, S; Simantov, R | 1 |
Guan, HJ; Ji, XQ; Wang, RG; Wu, WR; Zhu, XZ | 1 |
Quadri, SK; ThyagaRajan, S | 1 |
Mertz, K; Morgan, JI; Schmidt, J | 1 |
Castagnoli, K; Castagnoli, N; Palmer, S | 1 |
Gentsch, C; Spooren, WP; Waldmeier, P | 1 |
Croll, RP; Pani, AK | 1 |
Finberg, JP; Ilani, T; Lamensdorf, I | 1 |
Felten, DL; Madden, KS; Stevens, SY; ThyagaRajan, S | 1 |
MohanKumar, PS; MohanKumar, SM; Quadri, SK | 1 |
Adachi, YU; Higuchi, H; Satoh, T; Vizi, ES; Watanabe, K | 1 |
Barja, G; Fabre, E; Gredilla, R; Leret, ML; San Millán, JA | 1 |
Fisher, H; Halladay, AK; Hesse, K; Kirschner, E; Wagner, GC | 1 |
Fujimaru, S; Matsubara, K; Ohtaki, K; Saito, O; Shimizu, K; Shiono, H | 1 |
Antkiewicz-Michaluk, L; Herman, ZS; Obuchowicz, E; Romańska, I | 1 |
Adachi, K; Kondo, T; Kusumoto, H; Miwa, H; Shimazu, S | 1 |
Chen, Q; Davidson, C; Ellinwood, EH; Lazarus, C; Lee, TH; Xiong, X; Zhang, X | 1 |
Choudhury, ME; Kubo, M; Nagai, M; Nishikawa, N; Nomoto, M; Yabe, H | 1 |
1 review(s) available for 3,4-dihydroxyphenylacetic acid and selegiline
Article | Year |
---|---|
(-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Animals; Apoptosis; Cells, Cultured; Gene Expression Regulation; Humans; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Nerve Tissue Proteins; Neurites; Neuroglia; Neurons; Neuroprotective Agents; Nootropic Agents; Oxidative Stress; Parkinson Disease; Protein Synthesis Inhibitors; Rats; Selegiline | 1996 |
2 trial(s) available for 3,4-dihydroxyphenylacetic acid and selegiline
Article | Year |
---|---|
Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pituitary Hormones, Anterior; Random Allocation; Selegiline; Vanilmandelic Acid | 1989 |
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Double-Blind Method; Drug Interactions; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Selegiline | 1996 |
58 other study(ies) available for 3,4-dihydroxyphenylacetic acid and selegiline
Article | Year |
---|---|
Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Clorgyline; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Nitriles; Nitrophenols; Nomifensine; Rats; Rats, Inbred Strains; Selegiline; Tolcapone | 1992 |
Deprenyl alters behavior and caudate dopamine through an amphetamine-like action.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Behavior, Animal; Caudate Nucleus; Clorgyline; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selegiline | 1992 |
The effects of some neuroleptics and d-amphetamine on striatal 2-phenylethylamine in the mouse.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Chlorpromazine; Corpus Striatum; Dextroamphetamine; Dopamine; Fluphenazine; Homovanillic Acid; In Vitro Techniques; Male; Mice; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Selegiline; Spiperone; Synaptic Transmission | 1991 |
Effects of L-deprenyl and amantadine in an MPTP-model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Caudate Nucleus; Corpus Striatum; Dopamine; Drug Interactions; Female; Gerbillinae; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Parkinson Disease, Secondary; Selegiline; Serotonin | 1990 |
Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Ischemic Attack, Transient; Isoenzymes; Male; Monoamine Oxidase Inhibitors; Necrosis; Neurons; Nitriles; Pyrimidines; Rats; Rats, Inbred Strains; Reperfusion; Selegiline | 1991 |
The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Levodopa; Male; Rats; Selegiline | 1991 |
L-deprenyl, levodopa pharmacokinetics, and response fluctuations in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Humans; Levodopa; Middle Aged; Parkinson Disease; Phenethylamines; Psychomotor Performance; Selegiline | 1990 |
Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cerebral Cortex; Clorgyline; Corpus Striatum; Dopamine; Homovanillic Acid; Isoenzymes; Male; Monoamine Oxidase; Nucleus Accumbens; Pargyline; Rats; Rats, Inbred Strains; Reference Values; Selegiline | 1990 |
The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Limbic System; Mice; Motor Activity; Neurotransmitter Agents; Norepinephrine; Parkinson Disease, Secondary; Phenethylamines; Pyridinium Compounds; Selegiline; Serotonin | 1985 |
Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Desipramine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Nomifensine; Pyridines; Pyridinium Compounds; Selegiline; Serotonin | 1987 |
Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxydopamines; Male; Monoamine Oxidase Inhibitors; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains; Selegiline; Substantia Nigra; Tryptamines | 1989 |
Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Corpus Striatum; Dopamine; Male; Mazindol; Mice; Mice, Inbred BALB C; Monoamine Oxidase; Phenethylamines; Receptors, Dopamine; Selegiline | 1989 |
Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Male; Mice; Mice, Inbred BALB C; Parkinson Disease, Secondary; Phenethylamines; Pyridines; Selegiline; Time Factors | 1989 |
Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Clorgyline; Corpus Striatum; Debrisoquin; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nialamide; Norepinephrine; Rats; Rats, Inbred Strains; Selegiline | 1989 |
Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; B-Lymphocytes; Corpus Striatum; Designer Drugs; Ditiocarb; Dopamine; Homovanillic Acid; Immune System; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Metallothionein 3; Mice; Mitogens; Pyridines; Selegiline; T-Lymphocytes | 1989 |
A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Nervous System Diseases; Phenethylamines; Pyridines; Receptors, Dopamine; Selegiline | 1989 |
Investigation of dopamine content, synthesis, and release in the rabbit retina in vitro: I. Effects of dopamine precursors, reserpine, amphetamine, and L-DOPA decarboxylase and monoamine oxidase inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dopamine; Female; Levodopa; Male; Monoamine Oxidase Inhibitors; Pargyline; Rabbits; Reserpine; Retina; Selegiline; Tyrosine | 1986 |
Studies on the mechanism of the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Pyridines; Pyridinium Compounds; Receptors, Dopamine; Selegiline | 1987 |
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzylamines; Clorgyline; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Pyridines; Selegiline; Substantia Nigra; Synaptosomes; Tryptamines | 1985 |
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Binding Sites; Clorgyline; Corpus Striatum; Deamination; Dopamine; In Vitro Techniques; Male; Monoamine Oxidase; Oxidation-Reduction; Pargyline; Pyridines; Rats; Rats, Inbred Strains; Selegiline; Subcellular Fractions | 1985 |
Changes in dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in human cerebrospinal fluid after L-dopa and deprenyl administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benserazide; Dopamine; Humans; Levodopa; Monoamine Oxidase; Phenethylamines; Phenylacetates; Selegiline | 1983 |
Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Clorgyline; Corpus Striatum; Dopamine; In Vitro Techniques; Monoamine Oxidase; Phenethylamines; Propylamines; Rats; Rats, Inbred Strains; Selegiline; Time Factors | 1984 |
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Combinations; Female; Humans; Levodopa; Male; Methamphetamine; Middle Aged; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Selegiline; Tyramine | 1982 |
1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol depletes catecholamines in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cerebral Ventricles; Clorgyline; Corpus Striatum; Dopamine; Functional Laterality; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypothalamus; Infusions, Parenteral; Isoquinolines; Locus Coeruleus; Male; Microinjections; Norepinephrine; Organ Specificity; Raphe Nuclei; Rats; Rats, Wistar; Selegiline; Serotonin; Stereotaxic Techniques; Substantia Nigra; Thalamus | 1993 |
Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Corpus Striatum; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neurotransmitter Agents; Olfactory Pathways; Selegiline | 1995 |
Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dialysis; Dopamine; Homovanillic Acid; Indans; Levodopa; Male; Monoamine Oxidase Inhibitors; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline; Substantia Nigra | 1995 |
Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Dynorphins; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selegiline; Serotonin; Substantia Nigra | 1993 |
(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Ditiocarb; Dizocilpine Maleate; Dopamine; Drug Synergism; Haplorhini; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Piperazines; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1994 |
Dopamine metabolism in the guinea pig striatum: role of monoamine oxidase A and B.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Guinea Pigs; Homovanillic Acid; Male; Monoamine Oxidase; Pargyline; Selegiline | 1994 |
L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity?
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Dopamine; Homovanillic Acid; Hydroxyl Radical; Levodopa; Microdialysis; Mitochondria; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Stereotaxic Techniques; Substantia Nigra | 1994 |
L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Levodopa; Male; Monoamine Oxidase Inhibitors; Nerve Endings; Oxidopamine; Picolinic Acids; Rats; Rats, Sprague-Dawley; Selegiline | 1994 |
Effects of monoamine oxidase inhibitors on the acid metabolites of some trace amines and of dopamine in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amines; Animals; Corpus Striatum; Dopamine; Male; Methyldopa; Monoamine Oxidase Inhibitors; Phenylacetates; Piperidines; Rats; Rats, Wistar; Selegiline | 1993 |
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline | 1996 |
Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Caudate Nucleus; Dopamine; Frontal Lobe; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca fascicularis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Selegiline; Serotonin | 1995 |
High dose selegiline augments striatal ubiquinol in mouse: an indication of decreased oxidative stress or of interference with mitochondrial respiration? A pilot study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dose-Response Relationship, Drug; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase Inhibitors; Oxidative Stress; Oxygen Consumption; Pilot Projects; Selegiline; Ubiquinone | 1995 |
Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Drug Administration Schedule; Homovanillic Acid; Indans; Isoenzymes; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline; Time Factors | 1996 |
Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Blotting, Western; Dopamine; Dopamine Uptake Inhibitors; Free Radicals; Male; Nomifensine; Oxidative Stress; Proteins; Rats; Rats, Wistar; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1997 |
In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Clorgyline; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline | 1995 |
Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Clorgyline; Dopamine; Enzyme Activation; Homovanillic Acid; Injections, Intramuscular; Isoenzymes; Macaca radiata; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Organ Specificity; Selegiline | 1998 |
Effect of selegiline on dopamine concentration in the striatum of a primate.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Callithrix; Corpus Striatum; Dopamine; Extracellular Space; Female; Homovanillic Acid; Male; Microdialysis; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar; Selegiline | 1999 |
Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dopamine; Female; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Random Allocation; Selegiline; Time Factors | 1999 |
L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Body Weight; Brain; Dopamine; Eating; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Mammary Neoplasms, Experimental; Monoamine Oxidase Inhibitors; Norepinephrine; Prolactin; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Regulation of heme oxygenase-1 expression by dopamine in cultured C6 glioma and primary astrocytes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Astrocytes; Catechol O-Methyltransferase Inhibitors; Catechols; Cell Line; Cycloheximide; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glioma; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hemin; Membrane Proteins; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; RNA, Messenger; Selegiline; Time Factors; Tumor Cells, Cultured | 1999 |
Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Cattle; Corpus Striatum; Dopamine; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neuroprotective Agents; Neurotoxins; Selegiline | 1999 |
The effect of a subchronic post-lesion treatment with (-)-deprenyl on the sensitivity of 6-OHDA-lesioned rats to apomorphine and d-amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Medial Forebrain Bundle; Oxidopamine; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |
Catechol concentrations in the hemolymph of the scallop, Placopecten magellanicus.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechol O-Methyltransferase Inhibitors; Catecholamines; Chromatography, High Pressure Liquid; Clorgyline; Dihydroxyphenylalanine; Dopamine; Female; Hemolymph; Male; Mollusca; Monoamine Oxidase Inhibitors; Pargyline; Selegiline; Sexual Behavior, Animal | 2000 |
Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Catecholamines; Clorgyline; Corpus Striatum; Dialysis Solutions; Dihydroxyphenylalanine; Dopamine; Dopamine Uptake Inhibitors; Extracellular Space; Guinea Pigs; Homovanillic Acid; Isoenzymes; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperazines; Potassium Chloride; Rats; Selegiline; Synaptosomes; Tritium; Tyrosine 3-Monooxygenase | 2000 |
Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumors.
Topics: 3,4-Dihydroxyphenylacetic Acid; 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Division; Female; Flow Cytometry; Hydroxyindoleacetic Acid; Immune System; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Mammary Neoplasms, Experimental; Monoamine Oxidase Inhibitors; Neuroimmunomodulation; Norepinephrine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Spleen; Sympathetic Nervous System; Synaptic Transmission; T-Lymphocytes | 2000 |
Deprenyl stimulates the efflux of monoamines from the rat hypothalamus in vitro.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Hypothalamus; Male; Monoamine Oxidase Inhibitors; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin | 2001 |
Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Inhalation; Animals; Clorgyline; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hyperoxia; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxygen; Pargyline; Rats; Rats, Sprague-Dawley; Selegiline | 2001 |
Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Behavior, Animal; Catecholamines; Dopamine; Dopamine Agents; Glutathione; Male; Neostriatum; Oxidation-Reduction; Parkinson Disease, Secondary; Rats; Rats, Wistar; Selegiline; Stereotaxic Techniques | 2002 |
Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Clorgyline; Corpus Striatum; Dopamine; Drug Interactions; Fenclonine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin; Serotonin Antagonists; Tryptophan | 2001 |
Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; Herbicides; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Paraquat; Parkinsonian Disorders; Quinoxalines; Rats; Rats, Wistar; Selegiline | 2003 |
Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Chromatography, High Pressure Liquid; Clonidine; Corpus Striatum; Dopamine; Homovanillic Acid; Immunohistochemistry; Levodopa; Male; Mice; MPTP Poisoning; Neuropeptide Y; Neuroprotective Agents; Selegiline; Serotonin | 2003 |
Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Extracellular Space; Homovanillic Acid; Injections, Intraperitoneal; Levodopa; Male; Microdialysis; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline; Time Factors | 2006 |
Deprenyl treatment attenuates long-term pre- and post-synaptic changes evoked by chronic methamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Blotting, Western; Body Weight; Caudate Nucleus; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Immunochemistry; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Mesencephalon; Methamphetamine; Phosphorylation; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Selegiline; Substantia Nigra; Synapses; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Anticonvulsants; Biogenic Amines; Brain Chemistry; Callithrix; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Homovanillic Acid; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Neurons; Selegiline; Zonisamide | 2009 |